Estradiol enantate/algestone acetophenide
              < Estradiol enantate 
 
            
          | Combination of | |
|---|---|
| Estradiol enantate | Estrogen | 
| Algestone acetophenide | Progestogen | 
| Clinical data | |
| Trade names | Perlutal, Topasel, Unalmes, Yectames, many others | 
| Other names | Estradiol enantate/dihydroxyprogesterone acetophenide; E2-EN/DHPA | 
| Routes of administration | Intramuscular injection | 
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| UNII | |
Estradiol enantate/algestone acetophenide, also known as estradiol enantate/dihydroxyprogesterone acetophenide (E2-EN/DHPA) and sold under the brand names Perlutal and Topasel among others, is a form of combined injectable birth control which is used to prevent pregnancy. It contains estradiol enantate (E2-EN), an estrogen, and algestone acetophenide (dihydroxyprogesterone acetophenide; DHPA), a progestin. The medication is given once a month by injection into muscle.
E2-EN/DHPA is used widely throughout Latin America, is also marketed in Hong Kong, and was previously available in Portugal and Spain as well but was discontinued in these countries.